When comparing clinical and pathological variables between patients with early POD (n = 27, 37%) or late POD (n = 46, 63%), we found that MIPI (low-intermediate vs. high, p = 0.03), tumor morphology (p = 0.003), and TP53 mutation (p = 0.001) were significantly differentially represented between the two groups (Table 1). Here, TP53 is linked to neoplasm.